The Foundation 8-Stage Blueprint
We Don’t Just Calculate
Your Value. We Engineer
Your Leverage.
Know what buyers will challenge before they get the chance.
Before a buyer sees your practice, we identify the vulnerabilities they could use against you and build the financial case to defend your value. You receive a written Go or No-Go recommendation before deciding whether to enter the market.
If you move forward, we create competition among qualified buyers, protect your interests through negotiation and closing, and stay involved afterward to hold the buyer accountable for commitments made to you and your team.
You don’t have to be ready to sell. The first conversation is confidential and focused on your practice, your goals, and your options.
Beyond a Valuation
A Valuation Gives You a Number.
What Happens When a Buyer Challenges It?
A QoE Light analysis reviews your profit and loss statement, normalizes owner compensation and one-time expenses, and produces a directional adjusted EBITDA estimate. That gives you a starting number.
The number alone doesn’t defend itself when a buyer challenges it. Buyers scrutinize the earnings, assumptions, and risks behind it. You need the documentation and analysis to support your position when those questions come.
QoE Light is Zone 1 of our eight-zone framework. The Leverage Engineering Protocol examines the financial and operational factors institutional buyers use to decide what they’ll pay, how hard they’ll compete, and where they’ll challenge your position.
The Leverage Engineering Protocol
Eight zones. One financial case.
- 01EBITDA CoreQoE Light is Zone 1.
- 02Accounting Structure
- 03Labor Economics
- 04Provider Economics
- 05Clinical Economics
- 06Patient Economics
- 07Scheduling
- 08Real Estate and Facilities
250-plus analytical views across the framework.
Before anyone sits across the table from you, you should know the case for your value, where a buyer will challenge it, and how you’ll respond.
The Blueprint, Stage by Stage.
Every Foundation Dental Transitions engagement follows this eight-stage process. Each stage builds the foundation for what comes next, with a deliberate decision about entering the market before any buyer sees your practice.
Discovery
Understand your options before committing to a sale.
We start with a confidential conversation about your practice, your goals, and your situation. You leave with a clearer understanding of your options, an honest initial assessment of where you stand, and a direct answer about whether Foundation can help. No pitch. No pressure. You don’t have to be ready to sell to begin.
Engagement and Onboarding
Know what to expect and what happens next.
You enter the engagement with a clear plan, defined milestones, and an understanding of each phase ahead. We establish confidentiality protections and begin collecting the financial and operational documentation needed for the analysis. You know what’s happening and what we need from you.
Preparation
Resolve the gaps before you’re answering buyer requests.
Your financial and operational documents are collected, organized, and validated in a protected data room. We address missing information and inconsistencies before they become urgent diligence questions, so the analysis begins with a reliable record rather than a scramble for documents.
The Leverage Engineering Protocol
Build the financial case behind your number.
We examine your practice across eight zones and 250-plus analytical views to identify what supports your value and where a buyer will challenge it. Your earnings, operations, and risks become part of a documented financial case. You reach the next decision knowing the case for your value and how we’ll defend it.
See the full eight-zone breakdown below.
The Go/No-Go Checkpoint
Before a Single Buyer Sees Your Name.
At the conclusion of Stage 4, before your practice enters the market, we stop. We present the complete analysis and make a written Go or No-Go recommendation.
If the conditions support a market launch, we move forward together. If they don’t, we explain why and what would need to change. Either way, you have the findings behind the recommendation before making your decision.
We only earn a success fee when your transaction closes. We’d rather tell you the truth in Stage 4 than take you to market under conditions that don’t serve your interests.
You retain control. The decision to proceed, or not, is yours.
Buyer Positioning
Create competition, not just interest.
Your practice is presented in a Confidential Information Memorandum and supporting materials that explain its financial story, operational strengths, team, culture, and growth opportunities. The package gives qualified buyers a documented reason to compete. Nothing reaches a buyer without your review and approval.
Market to Buyers
Choose among qualified buyers, not whoever responds first.
We begin with a database of more than 350 active DSO buyers and systematically narrow the field against your criteria. Your practice isn’t simply blasted to a list. We evaluate financial strength, deal history, integration track record, and cultural alignment. You never negotiate alone. Every offer is reviewed and compared with you before you commit to anything.
LOI to Close
Protect your position when the terms come under pressure.
You have a dedicated quarterback from the signed letter of intent through closing, coordinating diligence, legal review, and negotiation. Buyer requests are managed before they reach you. Re-trading, the attempt to reduce the price or change the terms after the LOI, is scrutinized and challenged, with your attorney and CPA coordinated throughout. You don’t face the most demanding part of the transaction alone.
Legacy
Accountability after the wire clears.
Your post-close obligations, team communication, patient transition, and cultural continuity are addressed before the wire clears. We stay involved through integration to monitor commitments, address discrepancies, and hold the buyer accountable. A 90-day post-close check-in helps confirm whether the promises built into the deal are being kept. The engagement doesn’t end at the closing table, because the things that matter most don’t either.
Stage 4 in Depth
What the Financial Analysis
Actually Reveals.
A buyer won’t evaluate your practice from collections alone. The Leverage Engineering Protocol examines the earnings, operating structure, and growth capacity behind those collections, building the financial case you’ll need when the questions get specific.
Eight zones. 250-plus analytical views across the framework.
01EBITDA Core
Zone 1 rebuilds your financials from gross production through collections so the full waterfall can be traced and reconciled. Owner compensation and one-time expenses are normalized and documented, and issues are surfaced before a buyer begins testing the numbers.
This establishes the adjusted EBITDA behind your valuation, with financial records supporting every adjustment.
02Accounting Structure
We cross-reference your tax returns, balance sheet, debt, and receivables so your financials tell one consistent story. Buyers probe for inconsistencies between your P&L and your returns.
When the records already tie, that line of questioning loses its force before the first offer is in writing.
03Labor Economics
Every dollar spent on your team, including payroll, benefits, PTO, and contractors, is mapped and documented.
When staffing costs are already accounted for, a buyer has far less room to characterize them as an undocumented threat to margin or use them to argue for a lower price.
04Provider Economics
We show exactly how much each provider produces, what they cost, and how production is distributed across the practice. If production is well distributed, the records substantiate it.
If a large share depends on one doctor, we identify that concentration early and address how it affects earnings when your role changes, before a buyer raises it.
05Clinical Economics
We break down which procedures drive your revenue and what your insurance mix looks like. This shows buyers the quality and sustainability of your production, not just the volume.
A practice producing high margins from the right procedure mix typically commands a different multiple than one producing the same revenue less efficiently, and that difference belongs in your case.
06Patient Economics
Buyers pay for future cash flow potential. A healthy, growing patient pipeline materially strengthens that case. We quantify your active patient base, new patient flow, and retention rates.
The patient data needs to support the future earnings a buyer is being asked to underwrite.
07Scheduling
We measure your capacity utilization, missed appointments, and recare effectiveness. This shows buyers not just what your practice is worth today but what untapped revenue is sitting in your schedule.
A documented growth opportunity is worth more to a buyer than unused capacity, and the analysis establishes which one you have.
08Real Estate and Facilities
Buyers value favorable lease terms and room to add providers.
We analyze your lease, operatory layout, and physical growth capacity so that upside is documented, and any constraint is surfaced, before a buyer raises either.
The result is a financial case you can explain, document, and defend when a buyer challenges your position.
The Offense Versus Defense Principle
Every Vulnerability Is a Negotiating Tool.
The Question Is Who Finds It First.
Every practice has vulnerabilities. A buyer’s diligence team is trained to find them and test what they mean for value. When an issue surfaces for the first time in diligence, it can put price or terms under pressure. You’re playing defense on the buyer’s timetable. When we find it first in Stage 4, we have time to do something about it.
When the Buyer Finds It FirstThe issue arrives on the buyer’s terms, inside the buyer’s process. Their team asks the first question, supplies the first interpretation, and argues what it should mean for value. You’re responding on their timetable while price and terms are still being negotiated.
When We Find It FirstThe same issue is quantified before the market sees it. We document what can be corrected or mitigated, explain what remains, and show any upside the evidence supports. The conversation begins with evidence instead of surprise.
Provider Concentration
When the Buyer Finds It FirstOne doctor’s production is framed as a dependency that may not transfer.
When We Find It FirstThe concentration is measured, its effect on earnings is understood, and the response is prepared before a buyer asks.
Labor Inefficiencies
When the Buyer Finds It FirstStaffing expense is introduced as pressure on future margin.
When We Find It FirstPayroll, benefits, PTO, and contractor costs are already mapped, documented, and explained.
Scheduling Gaps
When the Buyer Finds It FirstOpen capacity is treated as underperformance.
When We Find It FirstUtilization, missed appointments, and recare data show what the schedule can realistically support and where the documented upside is.
Lease Risk
When the Buyer Finds It FirstRestrictive terms or limited physical capacity surface after the growth case has been presented.
When We Find It FirstLease terms, operatory capacity, and physical constraints are known and accounted for before the market sees the opportunity.
Finding the risk first doesn’t make it disappear. It gives you time to understand it, support your position, and decide what to do before a buyer decides what it means. The difference between those two outcomes is often measured in hundreds of thousands of dollars.
That shift from defense to offense is exactly why the financial model we build isn’t a valuation. It’s a positioning strategy.
The Experience Behind the Process
One of Us Was the Buyer.
One of Us Was the Seller.
We first sat across the table from each other when Brian was on the acquisition side of Dr. Arnold’s sale. Today, that shared history shapes how we evaluate buyers, negotiate terms, and prepare sellers for what follows the closing.
Acquisitions and Buyer Evaluation
Brian Mans
Co-Founder & Chief Executive Officer
Brian spent more than a decade on the acquisition side, working across 26 states, co-founding a DSO that grew to 114 practices, and executing a $214 million private equity exit. He has personally led more than 300 transactions and knows how acquisition teams test earnings, price risk, and structure terms. That experience now works on your side of the table. We evaluate interested buyers for financial strength, deal history, integration track record, and cultural alignment, so you understand who belongs on your shortlist and why.
Ownership and Life After Closing
Dr. Jim Arnold
Co-Founder & Chief Dental Officer
Dr. Jim Arnold spent 24 years building his practices, sold them, and then lived through the collapse of the DSO he joined. He knows the number on an offer matters, but so do your team, your role after closing, and the commitments you’ll depend on once the deal is done. His experience includes more than 60 practice transitions. He co-founded Foundation Dental Transitions to help dentists understand those commitments while they can still negotiate them, with team protections and integration built into the process rather than left to good faith.
The Process Starts
With One Conversation.
Before you decide whether to sell, understand your position.
You’ve seen how we prepare a practice, evaluate buyers, and protect the seller’s position through closing and integration. The first conversation is about what that process could mean for you: your practice, your timing, and what you want to protect.
We’ll discuss your options, answer your questions, and give you an honest initial assessment of whether Foundation can help. If it makes sense to explore further, we’ll explain the next step. You decide whether to take it.
Schedule Your Discovery CallYou don’t have to be ready to sell. The conversation is confidential and carries no obligation to move forward.